Because APOB ablation is significantly associated with poor prognosis of HCC patients and highly correlated with expression of cell growth-stimulating genes, such as MYC, FOXM1, HGF, and E2F1, we next tested if silencing APOB expression had any effects on the proliferation of HCC cells. This evidence concerns the gene FOXM1 and hepatocellular carcinoma.